Navigation Links
ACEA Biosciences Hires Roger Luo as Vice President of Global Clinical Development
Date:2/28/2017

ACEA Biosciences, a pioneer in cell analysis instrumentation and the development of novel pharmaceuticals for the treatment of chronic diseases, has announced Dr. Roger (Feng) Luo as the new Vice President of Global Clinical Development. With more than 15 years of clinical development experience with a number of multinational drug companies, Dr. Luo will now team with Dr. Li Xu, Chief Medical Officer, and Dr. Xiao Xu, President, to continue advancing the company’s lead drug candidate, AC0010. The drug candidate is currently in clinical trials for the treatment of non-small cell lung cancer (NSCLC) in both China and the US. A pyrrolopyrimidine-based irreversible inhibitor of the EGFR tyrosine kinase, AC0010 provides NSCLC patients with a new treatment alternative should first generation EGFR tyrosine kinase inhibitors fail to produce a durable response. Thus far, AC0010 has demonstrated efficacy, tolerability, and safety in clinical trials in both China and the U.S. Global clinical trials are slated for late 2017.

Before joining ACEA, Dr. Luo was Compound Development Team Lead, and Senior Leadership Member of Exploratory Medicine and Early Development at Johnson & Johnson (JNJ). Prior to JNJ, he was the Sr. Director of Early Clinical Development at Daiichi-Sankyo, and Head of the Tumor Pharmacology Group at Bristol-Myers Squibb. In total, Dr. Luo has participated in more than 20 oncology drug development trials around the globe, and has particular expertise in lung cancer therapeutics. “We are thrilled to have Roger join ACEA at this critical phase of the company’s history,” said Xiao Xu. “Roger’s experience and proficiency in drug development will be a major asset as we usher AC0010 through clinical trials.”

For more information about ACEA Biosciences, click here.

For further information please contact:                                                                                    
ACEA Biosciences, Inc.                                                                                                                
Dr. Jeff Xue                                                                                                                                    
Phone: +1 858 724 0928 x 3075                                                                                                
email: jxue(at)aceabio(dot)com

Read the full story at http://www.prweb.com/releases/2017/03/prweb14105641.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
2. Northstar Biosciences Launches All Natural Skincare Solutions
3. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
4. Sangamo BioSciences Announces Presentation At Regen Med Investor Day
5. Sangamo BioSciences Announces Presentation At The Needham Healthcare Conference
6. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
7. Quanta BioSciences qRT-PCR technology recommended in newly published CDC protocol for detection of H7N9 Avian Influenza
8. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
9. Provitro Biosciences Awarded First-Ever U.S. Patent For Large-Scale Production Of Bamboo Plants
10. Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference
11. Sangamo BioSciences Announces Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2019)... ... November 22, 2019 , ... ... hosted a live webinar covering a step-by-step cold chain validation guide to ... and cell therapies. Targeting complex cold chain biopharmaceutical industry leaders, the September ...
(Date:11/20/2019)... ... November 20, 2019 , ... Defense and aerospace ... electrical power generation units from 2019-2028. The value of this production is $728 ... 3,821 units worth $569 million. , Reference to 2017 is important, as ...
(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... announced today that they have been selected by Lantern Pharma to provided preclinical ... designed to obtain millions of data points using panels of unique and genetically ...
(Date:11/12/2019)... Wis. (PRWEB) , ... November 12, 2019 , ... ... food ingredient solutions for the food and beverage industry launched a new innovative ... improve the digital experience. Now, the website offers global visitors updated ingredient usage ...
Breaking Biology Technology:
(Date:11/20/2019)... ... ... BioInformatics Inc., part of Science and Medicine Group, the leading research and advisory ... Science Industry Awards for the most innovative new products in 2019. , Here are ... New Product – Cell Biology, Fluidigm (Gold Award) for ...
(Date:11/19/2019)... ... November 19, 2019 , ... ... preparation, and Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in ... Diagenode will offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring Bio-Rad’s Droplet Digital PCR technology, ...
(Date:11/19/2019)... ... November 19, 2019 , ... Hosted at the Las Vegas Convention Center, ... is the largest gathering of MJBiz business professionals in the world. With over ... every sector, there is no show quite like it. Atlantic Ultraviolet will exhibit at ...
Breaking Biology News(10 mins):